Fermion is happy to announce receiving CEP for Fluticasone Propionate. Certificate of suitability No R0-CEP 2020-008-Rev 00 was issued on 5th of August 2021. Fluticasone propionate belongs to corticosteroids and is used for inhaled, nasal and topical treatment of various symptoms such as asthma, COPD, allergic rhinitis and skin irritation. Both micronized and non-micronized Fluticasone is available from Fermion’s Oulu site in Finland.
